Literature DB >> 8030717

Angina and myocardial infarction with use of leuprolide acetate.

M J McCoy1.   

Abstract

Use of leuprolide acetate (Lupron) has been associated with angina in men, but there have been no previous reports of angina or myocardial infarction associated with its use in women. The first case of angina and myocardial infarction occurring in a woman undergoing treatment with leuprolide acetate depot is reported.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8030717     DOI： 10.1016/0002-9378(94)90486-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


  3 in total

1.  Myocardial infarction in a premenopausal woman with a decreased serum estrogen level due to leuprorelin acetate.

Authors:  Takeshi Sasaki; Toshio Kurosawa; Hiroshi Yamaguchi; Tomoyoshi Yanagisawa; Akiyoshi Arikawa; Hitoshi Takemura; Yasuko Ikeda; Tohru Izumi
Journal:  J Cardiol Cases       Date:  2010-02-06

Review 2.  Effects of gonadotrophin-releasing hormone outside the hypothalamic-pituitary-reproductive axis.

Authors:  D C Skinner; A J Albertson; A Navratil; A Smith; M Mignot; H Talbott; N Scanlan-Blake
Journal:  J Neuroendocrinol       Date:  2009-03       Impact factor: 3.627

3.  Myocardial Infarction in a Premenopausal Woman on Leuprolide Therapy.

Authors:  Irving E Perez; Mark A Menegus; Cynthia C Taub
Journal:  Case Rep Med       Date:  2015-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.